| |
|
|
Nicholas L. Teti, Jr.
Chairman
Declan Daly
Chief Executive Officer
Steven Morrell
Director
(2)(3)
Kenneth A. Selzer
Director
Henry Y.L. Toh
Director
(1)(2)
Terry Vandewarker
Director
(1)(3)(4)
Marshall G. Webb
Director
(1)(2)(3)
(1) Members of the Audit Committee.
(2) Members of the Compensation Committee.
(3) Members of the Corporate Governance Committee.
(4) Lead Independent Director.
Nicholas L. Teti, Jr. Chairman
Nicholas L. Teti, Jr. was appointed to Chairman and Chief Executive Officer (CEO) in June
2006. Mr. Teti has more than 30 years of industry experience. Prior to joining
Isolagen, he served as Chairman of the Board and CEO of Inamed Corporation, a
position he assumed in July 2001. Previously, Mr. Teti spent 25 years at DuPont
and DuPont Merck where he held a number of senior management positions including
President and CEO of DuPont Pharmaceuticals. Mr. Teti is an industry leader who
brings strong experience to Isolagen including an understanding of the
regulatory, clinical development and marketing process for products in the
biotechnology and pharmaceuticals industry. Mr. Teti earned an MBA in healthcare
administration and a BA in economics from St. Joseph’s University in
Philadelphia, PA.
Declan Daly,
Chief Executive Officer
Declan Daly was named Chief Executive Officer of Isolagen in January 2008. He
joined Isolagen as Chief Financial Officer (CFO) and Executive Vice President –
Europe in June 2006, and was promoted to Chief Operating Officer and CFO in June
2007. Prior to joining Isolagen, Mr. Daly spent more than seven years with
Inamed Corporation and most recently served as CFO. Prior to becoming CFO, Mr.
Daly served as Inamed's Senior Vice President, Corporate Controller and
Principal Accounting Officer, and previously as Vice President of Finance &
Administration of Inamed International Corp. based in Europe. Mr. Daly holds a
BA in Management Science and Industrial Systems Studies from Trinity College in
Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland.
Steven Morrell, Director
Steven Morrell was elected to the Board of Directors in May 2002. Since January
2001, Mr. Morrell has been a Partner at Teknoinvest Management AS, a Norwegian
venture capital firm investing in Scandinavia and the United States in the life
science and information technology sectors with $150 million under management. From January 1999 to January 2001, he was the Managing Director of a Teknoinvest
portfolio company, Aquasmart International AS. From January 1998 to February
1999, he was the General Director of Veropharm Co., Ltd. Mr. Morrell has held
numerous positions over the previous 14 years including: Managing Director for a
Merck & Co., Inc. subsidiary; General Director of Veropharm Co., Ltd., a Russian
pharmaceutical company; President of Hafslund Nycomed Pharma AG in Austria, and
management consultant in McKinsey & Co., Inc. He also served in the
U.S. Air Force as an officer. Mr. Morrell currently serves as a Member of the
Board of AKVAsmart ASA in Norway, Marical, Inc., Optinel Systems, Inc., CyVera
Corporation, Vaso Active Pharmaceuticals Inc. and OAO Pharmacy Chain 36.6 in
Russia. He holds an MBA from IMD, Switzerland and a BS degree with a
major in Mathematics and a minor in Aerospace Studies from Brigham Young
University.
Kenneth A. Selzer, Director
Dr. Kenneth A. Selzer was appointed to the Board of Directors in November 2007. Dr. Selzer has been a partner with the venture capital firm of Finistere Ventures. Concurrently, since 2005, Dr. Selzer has been executive director of the Hallowell-West Medical Center, which specializes in the diagnosis and treatment of patients with Attention Deficient Disorders (ADD/ADHD) and associated learning disorders. From 2002 until 2005, Dr. Selzer was a general partner with Neuropractice Consulting Group, which provides specialized services for companies investing in drugs, biologics and medical devices. Dr. Selzer is currently on the Board of Directors of INC Research, a global clinical research organization (CRO) and a company which he founded in 1996. Dr. Selzer is a graduate of both the UCLA School of Medicine and the OPM executive management program at Harvard Business School and is a Diplomat of both the American Board of Neurology and the American Board of Pain Medicine.
Henry Y.L. Toh, Director
Henry Y.L. Toh was appointed to the Board of Directors in January 2004. He is currently serving as a Director for four other publicly traded companies. Since 2001, Mr. Toh has served as a
Director of Teletouch Communications Inc. Since 1992, Mr.
Toh has served as an Officer and Director of Acceris Communications Inc., a
publicly held voice-over-IP company. Since December 1998, Mr. Toh has served as
a Director of National Auto Credit, Inc., a specialized finance and
entertainment company. From April 2002 until February 2004, Mr. Toh served as a
Director of Bigmar, Inc., a Swiss pharmaceuticals company. Since March 2004, he
has served as a Director of Crown Financial Group, Inc., a registered broker
dealer. Since September 2004, he has served as a Director of Vaso Active
Pharmaceuticals Inc. Since 1992, he has served as an officer and Director
of Four M International, Inc., a privately held offshore investment entity. Mr. Toh began his career with KPMG Peat, Marwick from 1980 to 1992, where he
specialized in international taxation and mergers and acquisitions. Mr. Toh is a
graduate of Rice University.
Terry Vandewarker, Director
Terry Vandewarker was appointed to the Board of Directors in October 2006. He
previously served as Director of Inamed Corporation from July 2003 to March
2006. He is currently a partner with a privately held family business. From July
1997 through July 2002, he held a number of senior operations and financial
management positions, including President and CEO at Encad, Inc., a publicly
traded NASDAQ company until its acquisition by Eastman Kodak in 2002. Prior to
joining Encad, he received extensive experience in senior accounting and finance
positions, including Vice President and Chief Financial Officer for NexCycle,
Inc from 1995 through 1997 and Vice President and Chief Financial Officer for
OCTUS, Inc. from 1993 through 1995. Prior to that he worked for a multi-national
investment company, an entertainment company and for Price Waterhouse. Mr.
Vandewarker is a Certified Public Accountant and holds a BS in Psychology from
the University of California at Riverside and an MBA in Accounting and Finance
from the University of California at Los Angeles.
Marshall G. Webb, Director
Marshall G. Webb was appointed to the Board of Directors in April 2004. Mr. Webb is
President of Polaris Group, an advisory firm he founded in January 1999 to
provide financial consulting and merger and acquisition services to public and
private companies. Since February 2003, he has served as Chief Executive Officer
of HWI Group, Inc., an early stage company formed to create security services
solutions for maritime and land-based facilities including private companies and
governmental agencies. Mr. Webb founded BrightStar Information Technology Group,
Inc., a global provider of information technology solutions to government and
business, and served as its Chief Executive Officer and as a Director from 1997
through 1998. Since 2001, Mr. Webb has served as a Director of Teletouch
Communications, Inc., and is a member of its Audit and Compensation committees. Mr. Webb was appointed to the Board of Directors of Omni Energy Services Corp.
in February 2004 and serves on its Audit Committee. Mr. Webb attended Southern
Methodist University, is a certified public accountant, and began his career
with Peat, Marwick, Mitchell & Co.
|
|
